Margaret E. McCann

(2<i>R</i>)-4-Oxo-4-[3-(Trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-<i>a</i>]pyrazin- 7(8<i>H</i>)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine:  A Potent, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes

Dooseop Kim, Liping Wang, Maria Beconi et al. · Journal of Medicinal Chemistry · 2004 · 808 citations · Full text

In vitro effects and in vivo efficacy of a novel cyclooxygenase-2 inhibitor in dogs with experimentally induced synovitis

Margaret E. McCann, Donald R. Andersen, Donghui Zhang et al. · American Journal of Veterinary Research · 2004 · 114 citations · Full text

Extracellular loop C of NPC1L1 is important for binding to ezetimibe

Adam B. Weinglass, Martin Köhler, Uwe Schulte et al. · Proceedings of the National Academy of Sciences · 2008 · 113 citations · Full text

Proteinlipid Interaction, Molecular Biology, Cytoskeleton +21

Selective PPARγ modulators with improved pharmacological profiles

Kun Liu, Regina M. Black, John J. Acton et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 62 citations · Full text

Molecular Pharmacology, G Protein-coupled Receptor, Medicine +6

Benzimidazolones: A New Class of Selective Peroxisome Proliferator-Activated Receptor γ (PPARγ) Modulators

Weiguo Liu, Fiona WaiYu Lau, Kun Liu et al. · Journal of Medicinal Chemistry · 2011 · 56 citations · Full text

Pharmacotherapy, Experimental Pharmacology, Gene Expression Profiling +17